Vicenne Sets Stock Market Records, Boosted by Public Health Prospects

In the first half of the year, Vicenne delivered slightly better-than-expected performance, with EBITDA rising by 64% and net income increasing by 80%. Management has confirmed its target of achieving record revenue exceeding one billion dirhams for the first time this year, with 527 million dirhams already realized by the end of June. These results reflect the strengthening of an integrated model that combines the distribution of advanced medical equipment, technical services, maintenance, and the treatment of infectious waste. This comprehensive offering positions Vicenne as a key player in the modernization of Morocco's healthcare system. Morocco is undergoing a significant healthcare revolution with the widespread implementation of Mandatory Health Insurance (AMO), the reform of Territorial Health Groups (GST), and a continuous increase in the health budget, strongly evidenced in the 2026 Finance Bill (PLF). These factors stimulate public demand for medical equipment and open unprecedented opportunities for well-positioned players like Vicenne. With its technical expertise and exclusive partnerships with global giants such as Elekta, Philips Medical Solutions, Beckman Coulter, Mindray, and Abbott, Vicenne is well-equipped to support this public dynamic, alongside the rapid growth of the private sector. The company relies on a robust network of over 1,800 clients and a portfolio of more than 200,000 references. The upward momentum of Vicenne's stock is set against a favorable backdrop for the entire healthcare sector. The reform of the public system, the increasing need for hospital infrastructure, and the rise in equipment spending announced in the 2026 Finance Bill serve as powerful catalysts for the sector. For investors, Vicenne represents the perfect blend of structural growth and financial solidity in a market where healthcare stocks remain scarce. Formerly known as Best Health, the company has accelerated its regional expansion since 2014, establishing a presence in Tunisia, Senegal, and Côte d'Ivoire. Vicenne is now implementing a "one-stop-shop" strategy to become the regional reference for integrated medical solutions. Fundraising efforts in 2025—220 million dirhams in capital in March, followed by a stock market introduction of 500 million dirhams—have strengthened its financial foundation and financed its growth and targeted acquisition strategy. In summary, Vicenne checks all the boxes: growth, visibility, local anchoring, and international ambition. This combination continues to attract interest on the Casablanca Stock Exchange and could well make the company one of the main stars of the market in 2025 and 2026.